Antonio Galvano

3.1k total citations
96 papers, 1.8k citations indexed

About

Antonio Galvano is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Antonio Galvano has authored 96 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 42 papers in Pulmonary and Respiratory Medicine and 32 papers in Cancer Research. Recurrent topics in Antonio Galvano's work include Lung Cancer Treatments and Mutations (27 papers), Cancer Genomics and Diagnostics (23 papers) and Colorectal Cancer Treatments and Studies (17 papers). Antonio Galvano is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Cancer Genomics and Diagnostics (23 papers) and Colorectal Cancer Treatments and Studies (17 papers). Antonio Galvano collaborates with scholars based in Italy, Belgium and Argentina. Antonio Galvano's co-authors include Viviana Bazan, Antonio Russo, Sérgio Rizzo, Francesco Passiglia, Angela Listì, Valerio Gristina, Lorena Incorvaia, Marta Castiglia, Antonio Russo and Christian Rolfo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Antonio Galvano

88 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antonio Galvano Italy	24	996	800	540	475	170	96	1.8k
Kai Li China	23	1.2k 1.2×	675 0.8×	341 0.6×	477 1.0×	106 0.6×	95	1.8k
Morena Fasano Italy	20	680 0.7×	535 0.7×	244 0.5×	605 1.3×	132 0.8×	63	1.4k
Nicola Battelli Italy	23	1.0k 1.0×	814 1.0×	553 1.0×	512 1.1×	112 0.7×	91	1.9k
Zhehai Wang China	22	1.0k 1.0×	844 1.1×	192 0.4×	445 0.9×	176 1.0×	81	1.7k
Alain Gelibter Italy	22	974 1.0×	574 0.7×	333 0.6×	332 0.7×	101 0.6×	100	1.4k
Matteo Rosellini Italy	14	590 0.6×	673 0.8×	293 0.5×	389 0.8×	73 0.4×	49	1.2k
Elena De Mattia Italy	25	963 1.0×	324 0.4×	279 0.5×	725 1.5×	200 1.2×	92	2.0k
Blair Marshall United States	9	630 0.6×	514 0.6×	487 0.9×	795 1.7×	103 0.6×	10	1.7k
Olivier Dubreuil France	15	932 0.9×	498 0.6×	382 0.7×	310 0.7×	154 0.9×	56	1.6k
Edgardo S. Santos United States	21	576 0.6×	524 0.7×	230 0.4×	384 0.8×	159 0.9×	101	1.2k

Countries citing papers authored by Antonio Galvano

Since Specialization

Citations

This map shows the geographic impact of Antonio Galvano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Galvano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Galvano more than expected).

Fields of papers citing papers by Antonio Galvano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Galvano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Galvano. The network helps show where Antonio Galvano may publish in the future.

Co-authorship network of co-authors of Antonio Galvano

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Galvano. A scholar is included among the top collaborators of Antonio Galvano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Galvano. Antonio Galvano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Incorvaia, Lorena, Cláudia Marchetti, Chiara Brando, et al.. (2025). BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study. ESMO Open. 10(2). 104076–104076. 2 indexed citations

Gristina, Valerio, Viviana Bazan, Nadia Barraco, et al.. (2025). On‐treatment dynamics of circulating extracellular vesicles in the first‐line setting of patients with advanced non‐small cell lung cancer: the LEXOVE prospective study. Molecular Oncology. 19(5). 1422–1435. 2 indexed citations

Incorvaia, Lorena, Tancredi Didier Bazan Russo, Valerio Gristina, et al.. (2024). The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors. npj Precision Oncology. 8(1). 190–190. 10 indexed citations

Pavan, Nicola, Fabio Fulfaro, Valerio Gristina, et al.. (2024). Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature. International Journal of Molecular Sciences. 25(19). 10683–10683.

Corsini, Lidia Rita, Chiara Brando, Alessandro Perez, et al.. (2024). 208P Role of plasma exosomes in crosstalk between immune system and hereditary ovarian cancer: Opportunity or challenge?. Annals of Oncology. 35. S300–S300. 1 indexed citations

Gristina, Valerio, Alessandro Perez, Nadia Barraco, et al.. (2024). Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family”. SHILAP Revista de lepidopterología. 3. 100136–100136. 8 indexed citations

Staropoli, Nicoletta, Domenico Ciliberto, Francesco Luciano, et al.. (2023). The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis. Critical Reviews in Oncology/Hematology. 193. 104229–104229. 4 indexed citations

Peri, Marta, Giuseppe Roberto Giammalva, Antonino Lupica, et al.. (2023). Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis. Diagnostics. 13(1). 144–144. 5 indexed citations

Incorvaia, Lorena, Chiara Brando, Alessandro Perez, et al.. (2023). Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients.. Journal of Clinical Oncology. 41(16_suppl). 10592–10592.

10.

Incorvaia, Lorena, Gaetana Rinaldi, Giuseppe Badalamenti, et al.. (2023). Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay. Therapeutic Advances in Medical Oncology. 15. 2596581–2596581. 13 indexed citations

11.

Brunetti, Oronzo, Afshin Derakhshani, Behzad Baradaran, et al.. (2020). COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?. Frontiers in Oncology. 10. 734–734. 30 indexed citations

12.

Badalamenti, Giuseppe, Nadia Barraco, Lorena Incorvaia, et al.. (2019). Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1. Journal of Oncology. 2019. 1–7. 12 indexed citations

13.

Santini, Daniele, Antonio Galvano, Francesco Pantano, et al.. (2019). How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials. Critical Reviews in Oncology/Hematology. 142. 68–75. 6 indexed citations

14.

Passiglia, Francesco, Massimo Di Maïo, Antonio Galvano, et al.. (2018). P1.13-16 The Diagnostic Accuracy of Circulating Tumor DNA for the Detection of EGFR-T790M Mutation in NSCLC: A Systematic Review and Meta-Analysis. Journal of Thoracic Oncology. 13(10). S588–S588. 1 indexed citations

15.

Rizzo, Sérgio, Antonio Galvano, Francesco Pantano, et al.. (2017). The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials. Critical Reviews in Oncology/Hematology. 120. 227–233. 14 indexed citations

16.

Passiglia, Francesco, Giuseppe Bronte, Viviana Bazan, et al.. (2016). Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 99. 150–157. 68 indexed citations

17.

Cicero, Giuseppe, et al.. (2016). Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel: A Prospective Single-Center Study. Oncology. 92(2). 94–100. 9 indexed citations

18.

Mancuso, Andrea, Alessandra Mazzola, Giuseppe Cabibbo, et al.. (2015). Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis. Digestive and Liver Disease. 47(4). 324–330. 46 indexed citations

19.

Donzelli, Alberto, et al.. (2015). Clinical Efficacy and Safety of Ezetimibe on Major Cardiovascular Endpoints: Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE. 10(4). e0124587–e0124587. 23 indexed citations

20.

Bronte, Giuseppe, Antonio Galvano, Giuseppe Cicero, et al.. (2014). Ramucirumab and its use in gastric cancer treatment. Drugs of today. 50(9). 613–613. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact